Issue 2, 2021
From the journal:

RSC Advances

Immune response and possible therapeutics in COVID-19

Anindya Dutta,†a   Ananya Roy,†a   Laboni Roy,†a   Samit Chattopadhyay*b  and  Subhrangsu Chatterjee ORCID logo *a  

* Corresponding authors

a Department of Biophysics, Bose Institute, Centenary Campus, P-1/12 C.I.T. Scheme VIIM, Kolkata-700054, India
E-mail: subhro_c@jcbose.ac.in, subhrangsu@gmail.com
Tel: +91-033-25693340

b BITS Pilani Goa Campus, NH-17B, Zuarinagar, Goa 403726, India
E-mail: samitc@goa.bitspilani.ac.in
Tel: +91-0832-2580856

Abstract

COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.

Graphical abstract: Immune response and possible therapeutics in COVID-19

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/D0RA08901J
Article type
Review Article
Submitted
19 Oct 2020
Accepted
24 Nov 2020
First published
04 Jan 2021
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2021,11, 960-977

Permissions

Request permissions

Immune response and possible therapeutics in COVID-19

A. Dutta, A. Roy, L. Roy, S. Chattopadhyay and S. Chatterjee, RSC Adv., 2021, 11, 960 DOI: 10.1039/D0RA08901J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements